COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE
COBRE:NDSU:管理员:针对疾病中的蛋白酶的新策略
基本信息
- 批准号:8360592
- 负责人:
- 金额:$ 100.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2012-09-23
- 项目状态:已结题
- 来源:
- 关键词:Applications GrantsAsthmaBiologicalBiologyBiomedical ResearchCenters of Research ExcellenceChemistryCore FacilityDiseaseFosteringFundingGoalsGrantGrowthHistonesHumanMalignant NeoplasmsMatrix MetalloproteinasesMolecular BiologyNational Center for Research ResourcesNorth DakotaPeptide HydrolasesPharmacologic SubstancePlayPrincipal InvestigatorResearchResearch InfrastructureResearch PersonnelResourcesRoleScienceSourceSynthesis ChemistryUnited States National Institutes of Healthbiomedical scientistcombatcookingcostmortalitynovel therapeuticsprograms
项目摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The Center for Protease Research was established in 2001 with funds from the COBRE program. The previous grant application had a strong focus on chemistry, while this continuation will have a strong biology component with cancer and asthma as the primary disease targets. Understanding the biological role played by matrix metalloproteinases and histone deacetylases in cancer and other diseases such as asthma will be a major scientific goal.
The Center will coordinate the expertise of 4 new investigators: Glenn Dorsam and Gregory Cook, Department of Chemistry and Molecular Biology; Bin Guo, Department of Pharmaceutical Sciences; and Jane Schuh, Department of Veterinary and Microbiological Sciences. Core Facilities in biology and synthetic chemistry will play a key role in assisting the research programs of the new PI's, other NDSU researchers, and North Dakota INBRE researchers. The Center will continue to build infrastructure, initiate new activities, and continue previously successful programs to foster growth of biomedical research in North Dakota.
Combating cancer, one of the leading causes of mortality in humans, is a major goal for biomedical scientists. The NDSU COBRE center will conduct research to provide fundamental information on how proteases, a key biological player in several diseases, impacts cancer. These studies have the potential to provide novel therapeutics that can treat this deadly disease.
这个子项目是利用这些资源的众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MUKUND P. SIBI其他文献
MUKUND P. SIBI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MUKUND P. SIBI', 18)}}的其他基金
COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE
COBRE:NDSU:管理员:针对疾病中的蛋白酶的新策略
- 批准号:
8167859 - 财政年份:2010
- 资助金额:
$ 100.79万 - 项目类别:
COBRE: NDSU: ADMIN: NEW STRATEGIES FOR TARGETING PROTEASE IN DISEASE
COBRE:NDSU:管理员:针对疾病中的蛋白酶的新策略
- 批准号:
7959599 - 财政年份:2009
- 资助金额:
$ 100.79万 - 项目类别:
相似海外基金
Testing the effectiveness of the biological drug, Tezepelumab, in patients with coexisting allergic rhinitis and allergic asthma
测试生物药物 Tezepelumab 对同时患有过敏性鼻炎和过敏性哮喘的患者的有效性
- 批准号:
490921 - 财政年份:2022
- 资助金额:
$ 100.79万 - 项目类别:
Studentship Programs
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
- 批准号:
10396626 - 财政年份:2021
- 资助金额:
$ 100.79万 - 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
- 批准号:
10216007 - 财政年份:2021
- 资助金额:
$ 100.79万 - 项目类别:
Air Pollution, Stress and Asthma Morbidity Risk: Role of Biological and Geospatial Markers
空气污染、压力和哮喘发病风险:生物和地理空间标记的作用
- 批准号:
10615633 - 财政年份:2021
- 资助金额:
$ 100.79万 - 项目类别:
Sex as a biological variable: Immunomodulatory mechanisms of Innate Defence Regulator (IDR) peptides in asthma
性别作为生物变量:先天防御调节剂 (IDR) 肽在哮喘中的免疫调节机制
- 批准号:
449782 - 财政年份:2020
- 资助金额:
$ 100.79万 - 项目类别:
Studentship Programs
Potential biological mechanisms with regard to the association betwen asthma and obesity
哮喘与肥胖之间关联的潜在生物学机制
- 批准号:
17K09599 - 财政年份:2017
- 资助金额:
$ 100.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
- 批准号:
7434307 - 财政年份:2008
- 资助金额:
$ 100.79万 - 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
- 批准号:
8092713 - 财政年份:2008
- 资助金额:
$ 100.79万 - 项目类别:
Childhood Asthma, Susceptibility and Biological Activity of Ambient Particles
儿童哮喘、环境颗粒物的易感性和生物活性
- 批准号:
7685408 - 财政年份:2008
- 资助金额:
$ 100.79万 - 项目类别:
Phenotypic and biological features of mucus plugs in asthma
哮喘粘液栓的表型和生物学特征
- 批准号:
10654049 - 财政年份:2005
- 资助金额:
$ 100.79万 - 项目类别:














{{item.name}}会员




